DRCP – Agreement of global targets heralds major progress in the fight against diabetes and noncommunicable diseases

Keeling, Ann

doi:10.1016/j.diabres.2012.11.014

Cited by 4 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…With more than three quarters of all chronic disease now occurring in developing country settings, the introduction of low cost research techniques that will provide the data required to inform government decision making is a priority [40]. DBS sample collection methods appear to have great potential for the evaluation of cardiometabolic risk factors at the population level [9,13,27] enabling data collection at scale in areas previously unstudied [15].…”

Section: Discussionmentioning

confidence: 99%

Comparability of HbA1c and lipids measured with dried blood spot versus venous samples: a systematic review and meta-analysis

et al. 2014

View full text Add to dashboard Cite

BackgroundLevels of haemoglobin A1c (HbA1c) and blood lipids are important determinants of risk in patients with diabetes. Standard analysis methods based upon venous blood samples can be logistically challenging in resource-poor settings where much of the diabetes epidemic is occurring. Dried blood spots (DBS) provide a simple alternative method for sample collection but the comparability of data from analyses based on DBS is not well established.MethodsWe conducted a systematic review and meta-analysis to define the association of findings for HbA1c and blood lipids for analyses based upon standard methods compared to DBS. The Cochrane, Embase and Medline databases were searched for relevant reports and summary regression lines were estimated.Results705 abstracts were found by the initial electronic search with 6 further reports identified by manual review of the full papers. 16 studies provided data for one or more outcomes of interest. There was a close agreement between the results for HbA1c assays based on venous and DBS samples (DBS = 0.9858venous + 0.3809), except for assays based upon affinity chromatography. Significant adjustment was required for assays of total cholesterol (DBS = 0.6807venous + 1.151) but results for triglycerides (DBS = 0.9557venous + 0.1427) were directly comparable.ConclusionsFor HbA1c and selected blood lipids, assays based on DBS samples are clearly associated with assays based on standard venous samples. There are, however, significant uncertainties about the nature of these associations and there is a need for standardisation of the sample collection, transportation, storage and analysis methods before the technique can be considered mainstream. This should be a research priority because better elucidation of metabolic risks in resource poor settings, where venous sampling is infeasible, will be key to addressing the global epidemic of cardiovascular diseases.

show abstract

Section: Discussionmentioning

confidence: 99%

Comparability of HbA1c and lipids measured with dried blood spot versus venous samples: a systematic review and meta-analysis

et al. 2014

View full text Add to dashboard Cite

show abstract

“…3 head of one of the constituent organizations of the NCD Alliance described the targets in glowing terms, as signaling "major progress in the fight against diabetes and noncommunicable diseases" (Keeling, 2013). They have now been incorporated into WHO's most recent Action Plan for preventing and controlling NCDs (World Health Organization, 2013b), and into the outcome resolution of a 2014 follow-up meeting of the General Assembly (United Nations General Assembly, 2014).…”

mentioning

confidence: 99%

The double burden of neoliberalism? Noncommunicable disease policies and the global political economy of risk

Glasgow

Schrecker

2015

Health & Place

View full text Add to dashboard Cite

Publisher's copyright statement: NOTICE: this is the author's version of a work that was accepted for publication in Health place. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reected in this document. Changes may have been made to this work since it was submitted for publication. A denitive version was subsequently published in Health place, 34, July 2015, 10.1016/j.healthplace.2015.06.005Additional information: Use policyThe full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for personal research or study, educational, or not-for-prot purposes provided that:• a full bibliographic reference is made to the original source • a link is made to the metadata record in DRO • the full-text is not changed in any way The full-text must not be sold in any format or medium without the formal permission of the copyright holders.Please consult the full DRO policy for further details. AbstractThe growing prevalence of NCDs in low-and middle-income countries (LMICs) is now recognized as one of the major global health policy issues of the early 21 st century. Current official approaches reflect ambivalence about how health policy should approach the social determinants of health identified by the WHO Commission on the topic that released its report in 2008, and in particular the role of macro-scale economic and social processes. Authoritative framing of options for NCD prevention in advance of the September, 2011 UN high-level meeting on NCDs arguably relied on a selective reading of the scientific (including social scientific) evidence, and foregrounded a limited number of risk factors defined in terms of individual behaviour: tobacco use, unhealthy diet, alcohol (ab)use and physical inactivity. The effect was to reproduce at a transnational level the individualization of responsibility for health that characterizes most health promotion initiatives in high-income countries, ignoring both the limited control that many people have over their exposure to these risk factors and the contribution of macro-scale processes like trade liberalization and the marketing activities of transnational corporations to the global burden of NCDs. An alternative perspective focuses on "the inequitable distribution of power, money, and resources" described by the WHO Commission, and the ways in which policies that address those inequities can avoid unintentional incorporation of neoliberal constructions of risk and responsibility.2

show abstract

Global Development and Population Health

Schrecker

Labonté

2019

Encyclopedia of Environmental Health

View full text Add to dashboard Cite

DRCP – Agreement of global targets heralds major progress in the fight against diabetes and noncommunicable diseases

Cited by 4 publications

References 0 publications

Comparability of HbA1c and lipids measured with dried blood spot versus venous samples: a systematic review and meta-analysis

Comparability of HbA1c and lipids measured with dried blood spot versus venous samples: a systematic review and meta-analysis

The double burden of neoliberalism? Noncommunicable disease policies and the global political economy of risk

Global Development and Population Health

Contact Info

Product

Resources

About